Switzerland And Philadelphia

NYON, Switzerland and PHILADELPHIA, November 18, 2011 - Shionogi and Shire to jointly develop and commercialize ADHD medicines in Japan Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has entered into an agreement with Shionogi & Co.